SCHEDULE 13GAccepted May 26, 5:10 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G
Accepted (ET)
5:10 PM
May 26, 2026
Filed
May 26, 2026
Documents
2
Size
17.7 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.